A rapid review is a form of evidence synthesis that uses streamlined systematic review methods to deliver results in 2 to 6 months instead of the 12 to 18 months required for a full systematic review. Rapid reviews make explicit, documented trade-offs between comprehensiveness and timeliness by limiting database searches, simplifying screening processes, or abbreviating quality assessment while maintaining transparency and reproducibility.
The distinction matters because researchers, policymakers, and health technology assessment agencies increasingly need evidence summaries faster than traditional systematic review timelines allow. The COVID-19 pandemic accelerated the adoption of rapid reviews, with hundreds published in response to urgent clinical questions. Understanding when a rapid review is appropriate and when a full systematic review is necessary is a critical methodological decision that affects the credibility and utility of your evidence synthesis.
What Is a Rapid Review?
The Cochrane Rapid Reviews Methods Group defines a rapid review as "a form of knowledge synthesis that accelerates the process of conducting a traditional systematic review through streamlining or omitting specific methods to produce evidence for stakeholders in a resource-efficient manner." This definition emphasizes that rapid reviews are not shortcuts that ignore methodology but rather deliberate adaptations that trade comprehensiveness for speed.
Key characteristics of rapid reviews include:
- Focused research question. Rapid reviews typically address narrower questions than comprehensive systematic reviews
- Fewer databases searched. Usually 2 to 3 databases instead of 5 to 7
- Single reviewer with verification. Instead of independent dual-reviewer screening
- Simplified data extraction. Shorter extraction forms focused on key outcomes
- Abbreviated quality assessment. May use simplified checklists instead of full RoB 2 or ROBINS-I assessments
- Narrative synthesis emphasis. Meta-analysis is performed only when clearly appropriate
How Rapid Reviews Differ From Systematic Reviews
The table below summarizes the key methodological differences between rapid reviews and full systematic reviews.
| Feature | Rapid Review | Systematic Review |
|---|---|---|
| Timeline | 2-6 months | 12-18 months |
| Databases searched | 2-3 | 4-7+ |
| Grey literature | Limited or excluded | Comprehensive |
| Screening | Single reviewer + verification | Dual independent reviewers |
| Data extraction | Single extractor + verification | Dual independent extractors |
| Quality assessment | Simplified or abbreviated | Full tool (RoB 2, ROBINS-I, NOS) |
| Synthesis | Usually narrative | Narrative and/or meta-analysis |
| Protocol registration | Recommended but less common | PROSPERO registration standard |
| PRISMA reporting | Adapted PRISMA | Full PRISMA 2020 |
| Update frequency | Often a one-time product | May be updated periodically |
The fundamental difference is not in the goals but in the depth of each methodological step. Both approaches aim to identify, appraise, and synthesize the best available evidence. Rapid reviews achieve this with documented shortcuts that are transparent to the reader. For a deeper comparison of evidence synthesis approaches, see our guides on systematic review vs literature review and types of systematic reviews.
When to Choose a Rapid Review
Rapid reviews are appropriate in specific circumstances where the full systematic review timeline is not feasible or not necessary.
Policy and Clinical Decision Urgency
Health technology assessment agencies, clinical guideline developers, and public health departments frequently need evidence summaries within weeks or months. Waiting 18 months for a full systematic review is not practical when a policy decision must be made now. The World Health Organization, National Institute for Health and Care Excellence (NICE), and the Canadian Agency for Drugs and Technologies in Health (CADTH) all commission rapid reviews for time-sensitive decisions.
Small or Well-Defined Evidence Base
When the body of evidence on a topic is small (fewer than 500 initial records from a comprehensive search), the time savings from dual-reviewer screening and exhaustive database searching are minimal. A rapid review may capture the same evidence with fewer resources. If preliminary scoping suggests that only 10 to 30 studies exist on a topic, a rapid review is often sufficient.
Updating an Existing Systematic Review
When a systematic review was published 2 to 3 years ago and needs updating, a rapid review approach can efficiently identify new evidence without repeating the entire process. The original review provides the methodological framework, and the rapid update searches only for studies published since the original search date.
Resource-Constrained Settings
Research teams in low-resource settings or those without dedicated funding for a full systematic review may find that a well-conducted rapid review provides actionable evidence within their constraints. A transparent rapid review is more valuable than an abandoned systematic review or a poorly conducted one.
When a Full Systematic Review Is Required
Cochrane or Journal-Mandated Standards
If your target publication venue is the Cochrane Database of Systematic Reviews or a journal that requires full systematic review methodology, a rapid review will not meet their standards. Some grant funders also require full systematic reviews as part of the funding justification.
Meta-Analysis Is the Primary Objective
If the main goal of your evidence synthesis is to produce a pooled effect estimate through meta-analysis, a full systematic review is strongly recommended. The abbreviated search of a rapid review may miss studies that would affect the pooled estimate, potentially biasing the results. Publication bias assessment is also less reliable when the search is not comprehensive.
High-Stakes Clinical Guidelines
Clinical practice guidelines that directly affect patient care should be based on the most comprehensive evidence synthesis available. While rapid reviews can inform interim guidelines, definitive guidelines typically require full systematic reviews with GRADE certainty assessments and Summary of Findings tables.
Regulatory Submissions
Pharmaceutical and medical device regulatory submissions to agencies like the FDA or EMA require comprehensive systematic reviews that meet specific methodological standards. Rapid reviews are not accepted for these purposes.
Not sure whether a rapid review or full systematic review fits your project? Our team conducts both, and we can advise you on the right approach based on your research question, timeline, and publication goals. Get a free quote for either approach, or explore our systematic review services and evidence synthesis services.
How to Conduct a Rapid Review: Step by Step
Step 1: Define the Scope and Protocol
Develop a focused research question using the PICO framework. Write a brief protocol that documents your search strategy, eligibility criteria, data extraction plan, and synthesis approach. Explicitly state which systematic review methods you will abbreviate and why. Consider registering your protocol on PROSPERO or the Open Science Framework.
Step 2: Search 2-3 Key Databases
Build a Boolean search strategy for your primary databases. For most health-related topics, search MEDLINE (via PubMed) and at least one additional relevant database. Use the same Boolean operator principles as a full systematic review but with a more focused set of search terms. Document your search strategy for reproducibility.
Step 3: Screen With Single Reviewer Plus Verification
One reviewer screens all titles and abstracts against your eligibility criteria. A second reviewer verifies a random sample of 10 to 20 percent of excluded records to check for missed inclusions. Full-text screening follows the same approach. This saves approximately 40 to 60 percent of the screening time compared to full dual-reviewer screening.
Step 4: Extract Data and Assess Quality
Use a simplified extraction form focused on your key outcomes. One reviewer extracts data, and a second reviewer verifies accuracy. For quality assessment, use abbreviated versions of standard tools or a simplified critical appraisal checklist. The Newcastle-Ottawa Scale is often used in rapid reviews because it is faster to apply than RoB 2.
Step 5: Synthesize and Report
Conduct a narrative synthesis organized by your research question components. If quantitative synthesis is appropriate, calculate effect sizes and consider a meta-analysis with explicit caveats about the non-exhaustive search. Report using the PRISMA checklist, noting any deviations from full systematic review methods. Use our PRISMA flow diagram generator to document your screening process.
Quality Considerations and Limitations
The primary limitation of rapid reviews is the potential for missing relevant studies due to fewer databases searched and less comprehensive grey literature coverage. Research comparing rapid reviews to systematic reviews on the same topic has found that rapid reviews identify 90 to 95 percent of the same studies when the evidence base is well-indexed in major databases. However, for topics where key evidence exists in grey literature, specialized databases, or non-English publications, the gap can be larger.
Other limitations include:
- Single-reviewer bias. Without independent dual screening, individual reviewer judgment errors are more likely to affect study selection
- Abbreviated quality assessment. Simplified critical appraisal may miss important methodological weaknesses in included studies
- Limited synthesis depth. Narrative synthesis without meta-analysis provides less precise estimates of treatment effects
- Reproducibility concerns. Some methodological shortcuts are harder to document transparently, reducing the reproducibility of the review
These limitations must be acknowledged explicitly in the discussion section of any rapid review. The value of a rapid review lies in providing the best available evidence within time constraints, not in claiming equivalence with a full systematic review.
Emerging Standards for Rapid Reviews
The methodology for rapid reviews is evolving rapidly. Several important developments are shaping the field.
The Cochrane Rapid Reviews Methods Group has published interim guidance on conducting rapid reviews within the Cochrane framework. This guidance provides recommendations for each phase of the review process, from protocol development through reporting.
PRISMA extension for rapid reviews is currently in development and will provide a standardized reporting framework specifically designed for rapid reviews. Until this is published, rapid reviewers should use the standard PRISMA 2020 checklist with documented deviations.
Living systematic reviews represent a related approach where the review is continuously updated as new evidence becomes available. Living reviews can begin with a rapid review approach and evolve into a comprehensive systematic review over time. This hybrid model is gaining acceptance in fields where the evidence base changes quickly.
Cost and Timeline Comparison
| Feature | Rapid Review | Systematic Review |
|---|---|---|
| DIY timeline | 2-6 months | 12-18 months |
| Professional service timeline | 4-6 weeks | 8-12 weeks |
| DIY cost | Researcher time only | Researcher time only |
| Professional service cost | $2,000-$6,000 | $5,000-$15,000 |
| Publication acceptance | Growing (most journals) | Universal |
| Meta-analysis possible | Yes, with caveats | Yes, standard |
| PROSPERO registrable | Yes | Yes |
The professional service timeline reflects the efficiency of dedicated teams with established workflows. For either approach, our team provides systematic review services that meet journal publication standards.
Frequently Asked Questions
The FAQ section below addresses the most common questions researchers ask about choosing between rapid and systematic reviews.